Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty revenues following a...
Search results for "new drug"
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug application for its dual-antibody...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment
The treatment landscape for metastatic breast cancer is undergoing a significant shift.
Statins: Are the Side Effects Real? New Research Challenges Common Fears
"Many people hesitate to take cholesterol medication because of side effects they’ve heard about through the...
Breaking the Resistance: New Cause for Glioblastoma Recurrence Identified
Glioblastoma is widely regarded as the most aggressive and devastating form of brain cancer.
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
Why ‘Elegant Dining’ Might Be the Secret to Appetite Control
If you typically rush through a sandwich at your desk or eat in a chaotic environment, you might be missing out on a...
Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops
Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in...